Skip to main content

Research Repository

Advanced Search

Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation

Bailey, James A.; Weller, Jill; Chapman, Caroline; Ford, Abby; Hardy, Katie; Oliver, Simon; Morling, Joanne R.; Simpson, J. Alastair; Humes, David J.; Banerjea, Ayan

Faecal immunochemical testing and blood tests for prioritization of urgent colorectal cancer referrals in symptomatic patients: a 2-year evaluation Thumbnail


Authors

James A. Bailey

Jill Weller

Caroline Chapman

Abby Ford

Katie Hardy

Simon Oliver

JOANNE MORLING JOANNE.MORLING@NOTTINGHAM.AC.UK
Clinical Associate Professor

J. Alastair Simpson

DAVID HUMES david.humes@nottingham.ac.uk
Clinical Associate Professor

Ayan Banerjea



Abstract

Background
A novel pathway incorporating faecal immunochemical testing (FIT) for rapid colorectal cancer diagnosis (RCCD) was introduced in 2017. This paper reports on the service evaluation after 2 years of pathway implementation.

Methods
The RCCD protocol was based on FIT, blood results and symptoms to stratify adult patients in primary care. Two-week-wait (2WW) investigation was indicated for patients with rectal bleeding, rectal mass and faecal haemoglobin (fHb) level of 10 µg Hb/g faeces or above or 4 µg Hb/g faeces or more in the presence of anaemia, low ferritin or thrombocytosis, in all other symptom groups. Patients with 100 µg Hb/g faeces or above had expedited investigation . A retrospective audit of colorectal cancer detected between 2017 and 2019 was conducted, fHb thresholds were reviewed and critically assessed for cancer diagnoses.

Results
In 2 years, 14788 FIT tests were dispatched with 13361 (90.4 per cent) completed returns. Overall, fHb was less than 4 µg Hb/g faeces in 9208 results (68.9 per cent), 4–9.9 µg Hb/g in 1583 (11.8 per cent), 10–99.9 µg Hb/g in 1850 (13.8 per cent) and 100 µg Hb/g faeces or above in 720 (5.4 per cent). During follow-up (median 10.4 months), 227 colorectal cancers were diagnosed. The cancer detection rate was 0.1 per cent in patients with fHb below 4 µg Hb/g faeces, 0.6 per cent in those with fHb 4–9.9 µg Hb/g faeces, 3.3 per cent for fHb 10–99.9 µg Hb/g faeces and 20.7 per cent for fHb 100 µg Hb/g faeces or above. The detection rate in the cohort with 10–19.9 µg Hb/g faeces was 1.4 per cent, below the National Institute for Health and Care Excellence threshold for urgent referral. The colorectal cancer rate in patients with fHb below 20 µg Hb/g faeces was less than 0.3 per cent.

Conclusion
Use of FIT to "rule out" urgent referral from primary care misses a small number of cases. The threshold for referral may be adjusted with blood results to improve stratification .

Journal Article Type Article
Acceptance Date Nov 15, 2020
Online Publication Date Mar 9, 2021
Publication Date Mar 9, 2021
Deposit Date Nov 24, 2020
Publicly Available Date Mar 10, 2022
Journal BJS Open
Print ISSN 2474-9842
Electronic ISSN 2474-9842
Publisher Wiley
Peer Reviewed Peer Reviewed
Volume 5
Issue 2
Article Number zraa056
DOI https://doi.org/10.1093/bjsopen/zraa056
Public URL https://nottingham-repository.worktribe.com/output/5067962
Publisher URL https://academic.oup.com/bjsopen/article/5/2/zraa056/6162967

Files





You might also like



Downloadable Citations